New paper: "Analysis of quality-adjusted time without symptoms or toxicity in patients with metastatic hormone-sensitive #prostatecancer from the #ARASENS trial," in the Euro J. Cancer by @WCMEnglanderIPM Clinical Dir. @CNSternberg on October 2nd.
https://t.co/ij5waG1CUK
Graduate Student Nishanth Chinnadurai, MS will present "Virtual T cell Modeling to Uncover Exhaustion-reversing Genetic Perturbations in T cells within
Preinvasive Lung #Adenocarcinoma," Friday at 11 am!
Graduate Student Nishanth Chinnadurai, MS will present "Virtual T cell Modeling to Uncover Exhaustion-reversing Genetic Perturbations in T cells within
Preinvasive Lung #Adenocarcinoma," Friday at 11 am!
Graduate Student Nishanth Chinnadurai, MS will present "Virtual T cell Modeling to Uncover Exhaustion-reversing Genetic Perturbations in T cells within
Preinvasive Lung #Adenocarcinoma," Friday at 11 am!
Don't miss tomorrow's @WCMEnglanderIPM#PrecisionMedicine Research Conference at 11 AM, “Germline Susceptibility in Biliary Tract Cancer: The Unresolved Significance of Uncertain Variant" by Andrea Perra, M.D., Ph.D.!
Don't miss our next @WCMEnglanderIPM#PrecisionMedicine Research Conference this Thursday
at 11 AM, “Germline Susceptibility in Biliary Tract Cancer: The Unresolved Significance of Uncertain Variant" by Andrea Perra, MD, PhD
Congratulations to @WCMEnglanderIPM Clinical Director Dr. Cora N. Sternberg (@cnsternberg) for her work as WCM's PI on this interesting study: "@FDA panel endorses first-of-a-kind cancer blood test from #Grail."
https://t.co/8o5JndlwT7
New from EIPM Clinical Dir. Dr. Sternberg (@cnsternberg), "Dosing, Safety, and Pharmacokinetics of Combination Therapy With Darolutamide, Androgen Deprivation Therapy, and Docetaxel for Metastatic Hormone-Sensitive #ProstateCancer in the #ARASENS Study."
https://t.co/W28sLdRxFX
In case you missed it, @WCMEnglanderIPM Member Dr. Howard Fine spoke with colleagues from @nyphospital about how a "Cerebral #Organoid Model Transforms #Glioblastoma Research."
https://t.co/wc5II1RgLj
Thanks @OncLearnNetwork for "Targeted Radionuclide Therapy Moves Earlier Across the Cancer Treatment Continuum," by @WCMEnglanderIPM's @DrScottTagawa on targeted radionuclide therapy and theranostics in #oncology.
https://t.co/XES0VtPi3K
The @WCMEnglanderIPM's Director Olivier Elemento, Ph.D. (@ElementoLab) joined WWJ Radio on October 9th to discuss how #AI could accelerate treatment discovery by analyzing patient data and uncovering disease mechanisms, including #lungcancer.
https://t.co/OG40vaQepy
The @WCMEnglanderIPM's Director Olivier Elemento, Ph.D. (@ElementoLab) joins WWJ Radio to discuss how #AI could accelerate treatment discovery by analyzing patient data and uncovering disease mechanisms, including #lungcancer:
https://t.co/OG40vaQepy
Don't miss our next @WCMEnglanderIPM#PrecisionMedicine Research Conference this Thursday
at 11 AM, “Germline Susceptibility in Biliary Tract Cancer: The Unresolved Significance of Uncertain Variant" by Andrea Perra, MD, PhD
Please join us in congratulating our @WCMEnglanderIPM Director Olivier Elemento, PhD (@ElementoLab) on earning the @NIH Director's Pioneer Award to build an artificial intelligence tool to accelerate cancer research! #AI#CommonFund#HighRiskHighReward
https://t.co/z8rRO3tTKb